Medifast (MED) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $13.15 +4.45%
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q3 EPS of $0.55, $0.04 better than the analyst estimate of $0.51. Revenue for the quarter came in at $77.2 million versus the consensus estimate of $74.94 million.
GUIDANCE:
Medifast sees Q4 2017 EPS of $0.46-$0.49. Medifast sees Q4 2017 revenue of $71.4-74.4 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfspeed (WOLF) Misses Q1 EPS by 147c; Offers Guidance
- McKesson (MCK) Tops Q2 EPS by 97c; raises guidance
- Blue Owl Technology Finance Corp. (OTF) Tops Q3 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
